AbbVie Stock Jumped Today: Deal Sparks New Outlook for Investors
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Overview of beginner-friendly HYSA options, focusing on accessibility, straightforward terms, and competitive rates.
24,631 articlesAbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Friday brought a dip in advanced micro devices stock as AI market optimism cooled. This guide breaks down the drivers...
In a wave of filings, multiple lawsuits claim hometap mischaracterized its HEI agreements and breached TILA, intensif...
Two healthcare ETFs offer very different paths for investors: a broad, low-cost core and a concentrated pharmaceutica...
A sharp escalation in the Middle East sees Iran strike U.S. military bases, triggering a broad market selloff and a s...
A record $182 billion in AI-focused bond issuance this year is fueling an infrastructure wave, but investors warn tha...
Between Dec 31, 2025 and July 10, 2026, the Global X AI & Technology ETF rose about 24.74%, while Arista Networks cli...
Rowe Price unveils an actively managed multi-crypto ETF on NYSE Arca, signaling traditional fund managers’ growing ap...
The U.S. government has expanded direct stakes in select public firms, tying national security goals to market moves ...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
In his first shareholder letter, Berkshire Hathaway’s new leader pledges continuity, a robust balance sheet, and read...